soul trial oral semaglutide cardiovascular outcomes nejm 2025 results 2024 Presented at ACC.25: Among participants SOUL: Oral Semaglutide Bests Usual – Oral Semaglutide Cuts Cardiovascular Risk
Pay in 4 interest-free payments of $7.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26




























